Market Cap 40.68M
Revenue (ttm) 230,000.00
Net Income (ttm) -24.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,830.43%
Debt to Equity Ratio 0.07
Volume 676,879
Avg Vol 566,012
Day's Range N/A - N/A
Shares Out 9.88M
Stochastic %K 9%
Beta 1.02
Analysts Strong Sell
Price Target $4.30

Latest News on IBIO

iBio to Begin Trading on the Nasdaq Stock Exchange

Feb 19, 2025, 4:05 PM EST - 6 weeks ago

iBio to Begin Trading on the Nasdaq Stock Exchange


iBio Reports Fiscal Second Quarter 2025 Financial Results

Feb 10, 2025, 4:05 PM EST - 7 weeks ago

iBio Reports Fiscal Second Quarter 2025 Financial Results


iBio Reports Fiscal First Quarter 2025 Financial Results

Nov 12, 2024, 4:05 PM EST - 5 months ago

iBio Reports Fiscal First Quarter 2025 Financial Results


iBio to Participate in Upcoming Investor Conferences

Sep 3, 2024, 7:00 AM EDT - 7 months ago

iBio to Participate in Upcoming Investor Conferences


iBio Closes Sale of Manufacturing Facility in Texas

Jun 3, 2024, 7:00 AM EDT - 10 months ago

iBio Closes Sale of Manufacturing Facility in Texas


iBio stock nearly tripled on Wednesday: here's why

Mar 27, 2024, 2:43 PM EDT - 1 year ago

iBio stock nearly tripled on Wednesday: here's why


iBio Announces $15.0 Million Private Placement

Mar 26, 2024, 7:35 PM EDT - 1 year ago

iBio Announces $15.0 Million Private Placement


iBio Amends and Extends Maturity of Credit Agreement

Dec 26, 2023, 7:15 AM EST - 1 year ago

iBio Amends and Extends Maturity of Credit Agreement


iBio, Inc. Announces Pricing of $4.5 Million Public Offering

Dec 5, 2023, 8:00 AM EST - 1 year ago

iBio, Inc. Announces Pricing of $4.5 Million Public Offering


iBio Announces Reverse Stock Split

Nov 27, 2023, 5:20 PM EST - 1 year ago

iBio Announces Reverse Stock Split


iBio Explains Recent Filing of Registration Statement

Oct 2, 2023, 6:45 AM EDT - 1 year ago

iBio Explains Recent Filing of Registration Statement


iBio Announces Filing of 2023 Annual Report on SEC Form 10-K

Sep 27, 2023, 4:19 PM EDT - 1 year ago

iBio Announces Filing of 2023 Annual Report on SEC Form 10-K


iBio Announces Amendment to Credit Agreement with Woodforest

Sep 21, 2023, 4:05 PM EDT - 1 year ago

iBio Announces Amendment to Credit Agreement with Woodforest


iBio Announces Proposed Underwritten Public Offering

Dec 6, 2022, 4:01 PM EST - 2 years ago

iBio Announces Proposed Underwritten Public Offering


iBio Announces CEO Departure

Dec 2, 2022, 4:30 PM EST - 2 years ago

iBio Announces CEO Departure


iBio, Inc. (IBIO) Q4 2022 Results - Earnings Call Transcript

Sep 27, 2022, 10:33 PM EDT - 2 years ago

iBio, Inc. (IBIO) Q4 2022 Results - Earnings Call Transcript